Panbela Therapeutics, Inc.
DelistedCIK 1029125fmd_1ACKRZQVQRE1S6W4X5GMJRCTQMManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2011 to Sep 30, 2024, 52 periods
Latest annual · FY2023
Millions- Operating income
- (26)
- Net income
- (25)
Latest quarter · Q3 FY2024
Millions- Operating income
- (7)
- Net income
- (7)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2018 to FY2023
- n/m
Panbela Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Operating income | -$25.6 million | -$34.1 million | 10-K 2024-03-26 · proof | |
| Net income | -$25.3 million | -$34.9 million | 10-K 2024-03-26 · proof | |
| Cash from operating activities | -$25.2 million | -$15.3 million | 10-K 2024-03-26 · proof | |
| Total assets | $11.8 million | $5 million | +137.1% | 10-K 2024-03-26 · proof |
| Total liabilities | $16.5 million | $13 million | +26.8% | 10-K 2024-03-26 · proof |
| Cash and cash equivalents | $2.6 million | $1.3 million | +100.6% | 10-K 2024-03-26 · proof |
- What was Panbela Therapeutics, Inc.'s operating income in fiscal 2023?
- Panbela Therapeutics, Inc. reported operating income of -$25.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$34.1 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
- What was Panbela Therapeutics, Inc.'s net income in fiscal 2023?
- Panbela Therapeutics, Inc. reported net income of -$25.3 million for fiscal 2023 (the year ended Dec 31, 2023), against -$34.9 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
- What was Panbela Therapeutics, Inc.'s cash from operating activities in fiscal 2023?
- Panbela Therapeutics, Inc. reported cash from operating activities of -$25.2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$15.3 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
- What are Panbela Therapeutics, Inc.'s total assets?
- As of Dec 31, 2023, Panbela Therapeutics, Inc. reported total assets of $11.8 million, against $5 million a year earlier (+137.1%). Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
- What are Panbela Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2023, Panbela Therapeutics, Inc. reported total liabilities of $16.5 million, against $13 million a year earlier (+26.8%). Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
- What are Panbela Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, Panbela Therapeutics, Inc. reported cash and cash equivalents of $2.6 million, against $1.3 million a year earlier (+100.6%). Source: the 10-K filed with the SEC on Mar 26, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1029125&period_type=annual&limit=5"Information only, not investment advice.